Journal of Experimental & Clinical Cancer Research (Oct 2019)

Activity of MCPIP1 RNase in tumor associated processes

  • Katarzyna Miekus,
  • Jerzy Kotlinowski,
  • Agata Lichawska-Cieslar,
  • Janusz Rys,
  • Jolanta Jura

DOI
https://doi.org/10.1186/s13046-019-1430-6
Journal volume & issue
Vol. 38, no. 1
pp. 1 – 11

Abstract

Read online

Abstract The monocyte chemoattractant protein-induced protein (MCPIP) family consists of 4 members (MCPIP1–4) encoded by the ZC3h12A-D genes, which are located at different loci. The common features of MCPIP proteins are the zinc finger domain, consisting of three cysteines and one histidine (CCCH), and the N-terminal domain of the PilT protein (PilT-N-terminal domain (PIN domain)). All family members act as endonucleases controlling the half-life of mRNA and microRNA (miRNA). The best-studied member of this family is MCPIP1 (also known as Regnase-1). In this review, we discuss the current knowledge on the role of MCPIP1 in cancer-related processes. Because the characteristics of MCPIP1 as a fundamental negative regulator of immune processes have been comprehensively described in numerous studies, we focus on the function of MCPIP1 in modulating apoptosis, angiogenesis and metastasis.

Keywords